TCG
MRK icon

Transcendent Capital Group’s Merck MRK Stock Holding History

Transcendent Capital Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,807
Closed -$217K – 134
2026
Q1 		$217K Sell
1,807
-275
-13% -$31.7K 0.1% 106
2025
Q4 		$219K Buy
+2,082
New +$195K 0.1% 112
2025
Q1 		– Sell
-1,398
Closed -$139K – 295
2024
Q4 		$139K Sell
1,398
-201
-13% -$20.7K 0.07% 118
2024
Q3 		$182K Sell
1,599
-12,288
-88% -$1.46M 0.09% 109
2024
Q2 		$1.72M Buy
13,887
+12,289
+769% +$1.58M 0.99% 29
2024
Q1 		$211K Buy
1,598
+250
+19% +$30.8K 0.12% 90
2023
Q4 		$147K Buy
+1,348
New +$140K 0.1% 89

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Transcendent Capital Group's MRK Position: Q2 2026 in Review

Transcendent Capital Group sold out of Merck (MRK) in Q2 2026, closing a stake of 1,807 shares — an estimated $217K sold.

Transcendent Capital Group first reported a position in MRK in Q4 2023 and held it in 7 quarters. The position peaked at $1.72M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Transcendent Capital Group reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Transcendent Capital Group sold 1,807 Merck shares in Q2 2026, an estimated $217K.
  • Transcendent Capital Group first reported a position in Merck in Q4 2023 and held it in 7 quarters.
  • Transcendent Capital Group's Merck position peaked at $1.72M in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Transcendent Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.